On Pharma Trends and Big Company Innovation
How does the world’s largest producer of medicines in terms of volume balance the science and the business of innovation? How does an enterprise at such vast scale make decisions about what to build vs. buy, especially given the fast pace of science today? How does it balance attitudes between “not invented here” and…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The a16z Show →
Moderna's CFO on How to Allocate Capital in Big Pharma
🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
Andreessen Horowitz's Vijay Pande: "AI doctors"
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.